These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 24124368)

  • 61. [HSV-TK gene therapy of lung adenocarcinoma xenografts using a hypoxia/radiation dual-sensitive promoter].
    Wang WD; Chen ZT; Li DZ; Duan YZ; Wang ZX; Cao ZH
    Ai Zheng; 2004 Jul; 23(7):788-93. PubMed ID: 15248913
    [TBL] [Abstract][Full Text] [Related]  

  • 62. DNA-liposome complexes transduction of herpes simplex virus thymidine kinase renders human tongue cancer cell line sensitive to ganciclovir in vitro.
    Wang JH; Situ ZQ; Wu JZ; Liu B
    Chin J Dent Res; 2000 Dec; 3(4):44-8. PubMed ID: 11314087
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A preliminary study on the construction of double suicide gene delivery vectors by mesenchymal stem cells and the in vitro inhibitory effects on SKOV3 cells.
    Jiang J; Wei D; Sun L; Wang Y; Wu X; Li Y; Fang Z; Shang H; Wei Z
    Oncol Rep; 2014 Feb; 31(2):781-7. PubMed ID: 24317390
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing.
    Wiewrodt R; Amin K; Kiefer M; Jovanovic VP; Kapoor V; Force S; Chang M; Lanuti M; Black ME; Kaiser LR; Albelda SM
    Cancer Gene Ther; 2003 May; 10(5):353-64. PubMed ID: 12719705
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Construction and identification of recombinant vectors carrying herpes simplex virus thymidine kinase genes expressed in vascular endothelial cells].
    Liu XP; Li BJ; Zhang C
    Ai Zheng; 2006 Feb; 25(2):179-84. PubMed ID: 16480582
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Construction of pGL3-hTERT-tk recombinant plasmid and effect of PEG-PEI/Fe(3)0(4) Nano-magnetic fluid-tk/GCV on proliferation of gastric cancer cells BGC823 in vitro].
    Buduwaili WS; Li L; Zhang BC
    Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Jul; 15(7):727-31. PubMed ID: 22851080
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Gene therapy using recombinant adenovirus carrying herpes simplex-thymidine kinase gene to treat mouse B 16 melanoma in vivo].
    Xu RE; Ying BB; Zhao SY; Li CB
    Shi Yan Sheng Wu Xue Bao; 1997 Sep; 30(3):261-71. PubMed ID: 11039021
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Expression of thymidine kinase mediated by a novel non-viral delivery system under the control of vascular endothelial growth factor receptor 2 promoter selectively kills human umbilical vein endothelial cells.
    Wang Y; Xu HX; Lu MD; Tang Q
    World J Gastroenterol; 2008 Jan; 14(2):224-30. PubMed ID: 18186559
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Noninvasive imaging of herpes virus thymidine kinase gene transfer and expression: a potential method for monitoring clinical gene therapy.
    Tjuvajev JG; Finn R; Watanabe K; Joshi R; Oku T; Kennedy J; Beattie B; Koutcher J; Larson S; Blasberg RG
    Cancer Res; 1996 Sep; 56(18):4087-95. PubMed ID: 8797571
    [TBL] [Abstract][Full Text] [Related]  

  • 70. In vivo imaging of herpes simplex virus type 1 thymidine kinase gene expression: early kinetics of radiolabelled FIAU.
    Haubner R; Avril N; Hantzopoulos PA; Gansbacher B; Schwaiger M
    Eur J Nucl Med; 2000 Mar; 27(3):283-91. PubMed ID: 10774880
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cancer-specific targeting of an adenovirus-delivered herpes simplex virus thymidine kinase suicide gene using translational control.
    Mathis JM; Williams BJ; Sibley DA; Carroll JL; Li J; Odaka Y; Barlow S; Nathan CO; Li BD; DeBenedetti A
    J Gene Med; 2006 Sep; 8(9):1105-20. PubMed ID: 16802401
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparative cytostatic activity of different antiherpetic drugs against herpes simplex virus thymidine kinase gene-transfected tumor cells.
    Balzarini J; Bohman C; Walker RT; de Clercq E
    Mol Pharmacol; 1994 Jun; 45(6):1253-8. PubMed ID: 8022417
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Preservation of the bystander cytocidal effect of irradiated herpes simplex virus thymidine kinase (HSV-tk) modified tumor cells.
    Vrionis FD; Wu JK; Qi P; Cano WG; Cherington V
    J Neurooncol; 1996 Dec; 30(3):225-36. PubMed ID: 8943097
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Efficacy of herpes simplex virus thymidine kinase in combination with cytokine gene therapy in an experimental metastatic breast cancer model.
    Majumdar AS; Zolotorev A; Samuel S; Tran K; Vertin B; Hall-Meier M; Antoni BA; Adeline E; Philip M; Philip R
    Cancer Gene Ther; 2000 Jul; 7(7):1086-99. PubMed ID: 10917212
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Monitoring adenoviral DNA delivery, using a mutant herpes simplex virus type 1 thymidine kinase gene as a PET reporter gene.
    Liang Q; Nguyen K; Satyamurthy N; Barrio JR; Phelps ME; Gambhir SS; Herschman HR
    Gene Ther; 2002 Dec; 9(24):1659-66. PubMed ID: 12457279
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Novel (E)-5-(2-iodovinyl)-2'-deoxyuridine derivatives as potential cytostatic agents against herpes simplex virus thymidine kinase gene transfected tumors.
    Balzarini J; Morin KW; Knaus EE; Wiebe LI; De Clercq E
    Gene Ther; 1995 Jul; 2(5):317-22. PubMed ID: 7671107
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Effects of herpes simplex virus thymidine kinase gene transduction and prodrug on ovarian cancer cell].
    Liang Z; Kuang J; Lin Z
    Zhonghua Fu Chan Ke Za Zhi; 1997 Aug; 32(8):467-70. PubMed ID: 9639739
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Molecular imaging with 123I-FIAU, 18F-FUdR, 18F-FET, and 18F-FDG for monitoring herpes simplex virus type 1 thymidine kinase and ganciclovir prodrug activation gene therapy of cancer.
    Wang HE; Yu HM; Liu RS; Lin M; Gelovani JG; Hwang JJ; Wei HJ; Deng WP
    J Nucl Med; 2006 Jul; 47(7):1161-71. PubMed ID: 16818951
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effective treatment of experimental glioblastoma by HSV vector-mediated TNF alpha and HSV-tk gene transfer in combination with radiosurgery and ganciclovir administration.
    Niranjan A; Moriuchi S; Lunsford LD; Kondziolka D; Flickinger JC; Fellows W; Rajendiran S; Tamura M; Cohen JB; Glorioso JC
    Mol Ther; 2000 Aug; 2(2):114-20. PubMed ID: 10947938
    [TBL] [Abstract][Full Text] [Related]  

  • 80. In vitro targeting of NG2 antigen by 213Bi-9.2.27 alpha-immunoconjugate induces cytotoxicity in human uveal melanoma cells.
    Li Y; Wang J; Rizvi SM; Jager MJ; Conway RM; Billson FA; Allen BJ; Madigan MC
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4365-71. PubMed ID: 16303921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.